General Information
Revision date
2021-08-02
Product name
TELZIR / LEXIVA ORAL SUSPENSION
Product Synonyms
TELZIR ORAL SUSPENSION 50 MG/ML * LEXIVA ORAL SUSPENSION 50 MG/ML *
CAS No.
226700-81-8
1.2.2. Uses advised against
No other uses are advised
Manufacturer Name
ViiV
Icons in SDS
Company Information
company name
ViiV
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H351, H361, H362, H373
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
Physical hazards
Not classified.
Health hazards
Sensitization, skin Category 1 Carcinogenicity Category 2 Reproductive toxicity Category 2 Reproductive toxicity Effects on or via lactation Specific target organ toxicity following Category 2 repeated exposure
Environmental hazards
Not classified.
Signal word
Warning
Hazard statements
H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H361 Suspected of damaging fertility or the unborn child. H362 May cause harm to breast-fed children. H373 May cause damage to organs through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe mist/vapours. P263 Avoid contact during pregnancy/while nursing. P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/attention. P321 Specific treatment (see on this label). P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container (in accordance with related regulations).
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
1 % of the mixture consists of component(s) of unknown acute oral toxicity. 7.1 % of the mixture consists of component(s) of unknown acute dermal toxicity. 7.1 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 7.1 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. National/local information Not available.
